𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HER2/neu over-expression induces endothelial cell retraction

✍ Scribed by W. Bradford Carter; James B. Hoying; Carl Boswell; Stuart K. Williams

Publisher
John Wiley and Sons
Year
2001
Tongue
French
Weight
157 KB
Volume
91
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Small interfering RNA (siRNA) inhibits t
Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines
✍ Aniruddha Choudhury; Jehad Charo; Sunil K. Parapuram; Richard C. Hunt; D. Margar πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 430 KB

## Abstract Silencing of a specific mRNA using double stranded RNA oligonucleotides represents one of the newest technologies for suppressing a specific gene product. Small interfering RNA (siRNA) are 21 nucleotides long, double stranded RNA fragments that are identical in sequence to the target mR

A novel recombinant fusion toxin targeti
A novel recombinant fusion toxin targeting HER-2/NEU–over-expressing cells and containing human tumor necrosis factor
✍ Michael G. Rosenblum; Shirley A. Horn; Lawrence H. Cheung πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 152 KB

Over-expression of the proto-oncogene HER2/neu in breast cancer and certain other tumors appears to be a central mechanism that may be partly responsible for cellular progression of the neoplastic phenotype. Transfection of mammalian cells and over-expression of HER2/neu appears to result in reduced

Effects of the tyrosine-kinase inhibitor
Effects of the tyrosine-kinase inhibitor geldanamycin on ligand-induced HER-2/NEU activation, receptor expression and proliferation of HER-2-positive malignant cell lines
✍ Frank Hartmann; Eva M. Horak; Cheryl Cho; Ruth Lupu; Joseph B. Bolen; Mary A. St πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 408 KB πŸ‘ 2 views

Geldanamycin belongs to the family of benzoquinoid ansamycin tyrosine-kinase inhibitors. We have examined its effects on Her-2/neu kinase activity, protein expression level, and proliferation of Her-2+ malignant cells. In SK-BR-3 breast-cancer cells, short-time treatment with geldanamycin completely